Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 545
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Biofel PCH - V/NRP/17/0005 Bioveta, a.s., Čehija QI06AA04 cats Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated feline panleucopenia virus, strain FPV Bio 7,Inactivated feline calicivirus, strain FCV F9 Bio-8,Inactivated feline herpes virus, strain FHV 1 Bio-9
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 20-Dec-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 211221LI (21-Dec-2021)
Labelling text: [DOCX] 211221M (21-Dec-2021)
Summary of product characteristics: [DOC] 211221ZA (21-Dec-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/17/0005-01 2 Stikla flakons, 1 deva -
V/NRP/17/0005-02 10 Stikla flakons, 1 deva -
V/NRP/17/0005-03 5 Stikla flakons, 5 deva -
V/NRP/17/0005-04 10 Stikla flakons, 5 deva -
V/NRP/17/0005-05 20 Stikla flakons, 1 deva -
V/NRP/17/0005-06 100 Stikla flakons, 1 deva -
V/NRP/17/0005-07 1 Stikla flakons, 5 deva -
BIO KILL 2,5 mg/1 ml spray 2.5 mg/ml V/NRP/99/0989 Bioveta, a.s., Čehija QP53AC04 domestic animals Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, solution
International name (active substance): Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 30-Apr-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 300913LI (03-Oct-2013)
Labelling text: [PDF] 300913M (03-Oct-2013)
Summary of product characteristics: [PDF] 300913ZA (03-Oct-2013)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0989-01 2,5 mg/ml 1 Polietilēna flakons, 100 ml -
V/NRP/99/0989-09 2,5 mg/ml 1 Flakons, 500 ml -
Phenosan 12.5 mg V/DCP/25/0009 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0009-01 1 Blisteris, 10 tablete -
V/DCP/25/0009-02 2 Blisteris, 10 tablete -
V/DCP/25/0009-03 3 Blisteris, 10 tablete -
V/DCP/25/0009-04 4 Blisteris, 10 tablete -
V/DCP/25/0009-05 5 Blisteris, 10 tablete -
V/DCP/25/0009-06 6 Blisteris, 10 tablete -
V/DCP/25/0009-07 7 Blisteris, 10 tablete -
V/DCP/25/0009-08 8 Blisteris, 10 tablete -
V/DCP/25/0009-09 9 Blisteris, 10 tablete -
V/DCP/25/0009-10 10 Blisteris, 10 tablete -
V/DCP/25/0009-11 25 Blisteris, 10 tablete -
Phenosan 50 mg V/DCP/25/0010 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0010-01 1 Blisteris, 10 tablete -
V/DCP/25/0010-02 2 Blisteris, 10 tablete -
V/DCP/25/0010-03 3 Blisteris, 10 tablete -
V/DCP/25/0010-04 4 Blisteris, 10 tablete -
V/DCP/25/0010-05 5 Blisteris, 10 tablete -
V/DCP/25/0010-06 6 Blisteris, 10 tablete -
V/DCP/25/0010-07 7 Blisteris, 10 tablete -
V/DCP/25/0010-08 8 Blisteris, 10 tablete -
V/DCP/25/0010-09 9 Blisteris, 10 tablete -
V/DCP/25/0010-10 10 Blisteris, 10 tablete -
V/DCP/25/0010-11 25 Blisteris, 10 tablete -
Vetmedin S 1.25 mg V/MRP/15/0011 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0011-01 1,25 mg 2 PVH/Al blisteris, 10 tablete -
V/MRP/15/0011-02 1,25 mg 5 PVH/Al blisteris, 10 tablete -
V/MRP/15/0011-03 1,25 mg 10 PVH/Al blisteris, 10 tablete -
Cladaxxa 40 mg/10 mg - V/MRP/22/0006 KRKA d.d. Novo Mesto, Slovēnija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 15122023LI (15-Dec-2023)
Labelling text: [DOCX] 15122023M (15-Dec-2023)
Summary of product characteristics: [DOCX] 15122023ZA (15-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0006-01 1 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0006-02 2 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0006-03 10 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0006-04 50 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
Cladaxxa 200 mg/50 mg - V/MRP/22/0007 KRKA d.d. Novo Mesto, Slovēnija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 15122023LI (15-Dec-2023)
Labelling text: [DOCX] 15122023M (15-Dec-2023)
Summary of product characteristics: [DOCX] 15122023ZA (15-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0007-01 1 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0007-02 2 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0007-03 10 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0007-04 50 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
Cladaxxa 400 mg/100 mg - V/MRP/22/0008 KRKA d.d. Novo Mesto, Slovēnija QJ01CR02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 15122023LI (15-Dec-2023)
Labelling text: [DOCX] 15122023M (15-Dec-2023)
Summary of product characteristics: [DOCX] 15122023ZA (15-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0008-01 2 OPA/Al/PE/desikants/Al/PE blisteris, 6 tablete -
V/MRP/22/0008-02 10 OPA/Al/PE/desikants/Al/PE blisteris, 6 tablete -
V/MRP/22/0008-03 50 OPA/Al/PE/desikants/Al/PE blisteris, 6 tablete -
Furosoral vet 40 mg V/MRP/14/0063 Le Vet Beheer B.V., Nīderlande QC03CA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Furosemide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 20032024LI (20-Mar-2024)
Labelling text: [DOCX] 20032024M (20-Mar-2024)
Summary of product characteristics: [DOCX] 20032024ZA (20-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0063-01 40 mg 1 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-02 40 mg 2 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-03 40 mg 3 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-04 40 mg 4 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-05 40 mg 5 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-06 40 mg 6 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-07 40 mg 7 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-08 40 mg 8 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-09 40 mg 9 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-10 40 mg 10 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-11 40 mg 25 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-12 40 mg 50 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-13 40 mg 100 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-14 40 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-15 40 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-16 40 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-17 40 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-18 40 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-19 40 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-20 40 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
BioBos Respi 3 - V/MRP/18/0040 Bioveta, a.s., Čehija QI02AL04 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated bovine respiratory syncytial virus, strain BIO-24,Inactivated bovine parainfluenza-3 virus, strain BIO-23,Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0040-01 1 Plastmasas flakons, 5 deva -
V/MRP/18/0040-02 1 Plastmasas flakons, 25 deva -
V/MRP/18/0040-03 1 Plastmasas flakons, 50 deva -
V/MRP/18/0040-04 1 Stikla flakons, 5 deva -
V/MRP/18/0040-05 1 Stikla flakons, 25 deva -
V/MRP/18/0040-06 1 Stikla flakons, 50 deva -
V/MRP/18/0040-07 10 Plastmasas flakons, 5 deva -
V/MRP/18/0040-08 10 Stikla flakons, 5 deva -
V/MRP/18/0040-09 10 Plastmasas flakons, 5 deva -
V/MRP/18/0040-10 10 Stikla flakons, 5 deva -
BioBos Respi 4 - V/MRP/18/0041 Bioveta, a.s., Čehija QI02AL cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated bovine respiratory syncytial virus, strain BIO-24,Inactivated bovine parainfluenza-3 virus, strain BIO-23,Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1,Inactivated bovine viral diarrhea virus, strain BIO-25
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0041-01 1 Plastmasas flakons, 5 deva -
V/MRP/18/0041-02 1 Plastmasas flakons, 25 deva -
V/MRP/18/0041-03 1 Plastmasas flakons, 50 deva -
V/MRP/18/0041-04 1 Stikla flakons, 5 deva -
V/MRP/18/0041-05 1 Stikla flakons, 25 deva -
V/MRP/18/0041-06 1 Stikla flakons, 50 deva -
V/MRP/18/0041-07 10 Plastmasas flakons, 5 deva -
V/MRP/18/0041-08 10 Stikla flakons, 5 deva -
V/MRP/18/0041-09 10 Stikla flakons, 5 deva -
V/MRP/18/0041-10 10 Plastmasas flakons, 5 deva -
HuveGuard MMAT - V/MRP/16/0025 Huvepharma NV, Beļģija QI01AN01 chickens Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral suspension
International name (active substance): Eimeria acervulina (strain RA|3+20), Eimeria maxima (strain MCK+10), Eimeria mitis (strain Jormit 3+9), Eimeria tenella (strain Rt 3+15)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, Bulgārija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/16/0025-01 1 ZBPE flakons, 1000 deva -
V/MRP/16/0025-02 5 ZBPE flakons, 1000 deva -
V/MRP/16/0025-03 10 ZBPE flakons, 1000 deva -
V/MRP/16/0025-04 1 ZBPE flakons, 5000 deva -
V/MRP/16/0025-05 5 ZBPE flakons, 5000 deva -
V/MRP/16/0025-06 10 ZBPE flakons, 5000 deva -
Quiflox 5 mg V/DCP/12/0073 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0073-01 5 mg 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/12/0073-02 5 mg 10 OPA/Al/PVH-Al blisteris, 10 tablete -
Quiflox 20 mg V/DCP/12/0074 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0074-01 20 mg 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/12/0074-02 20 mg 10 OPA/Al/PVH-Al blisteris, 10 tablete -
Dinolytic 5 mg/ml V/NRP/93/0031 Zoetis Belgium S.A., Beļģija QG02AD01 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dinoproston tromethamine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija;Zoetis Manufacturing & Research Spain, S.L. , Spānija
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_aprakst (02-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0031-02 5 mg/ml 5 stikla flakons bez pretplūsmas (ar sarkanu aizbāzni), 10 ml -
V/NRP/93/0031-03 5 mg/ml 1 stikla flakons bez pretplūsmas (ar sarkanu aizbāzni), 30 ml -
V/NRP/93/0031-04 5 mg/ml 1 stikla flakons bez pretplūsmas (ar sarkanu aizbāzni), 100 ml -
V/NRP/93/0031-05 5 mg/ml 5 stikla flakons ar pretplūsmu (ar sarkanu aizbāzni), 10 ml -
V/NRP/93/0031-06 5 mg/ml 5 stikla flakons bez pretplūsmas (ar pelēku aizbāzni), 10 ml -
V/NRP/93/0031-07 5 mg/ml 1 stikla flakons bez pretplūsmas (ar pelēku aizbāzni), 30 ml -
V/NRP/93/0031-08 5 mg/ml 1 stikla flakons bez pretplūsmas (ar pelēku aizbāzni), 100 ml -
V/NRP/93/0031-09 5 mg/ml 5 stikla flakons ar pretplūsmu (ar pelēku aizbāzni), 10 ml -
Valbendis 100 mg/ml V/DCP/25/0019 Industrial Veterinaria, S.A., Spānija QP52AC11 cattle; sheep Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Albendazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 24-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0019-01 1 ABPE pudele, 1 l -
V/DCP/25/0019-02 1 ABPE pudele, 5 l -
MYXOREN - V/NRP/02/1433 Bioveta, a.s., Čehija QI08AD02 rabbits Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Myxoma virus, strain CAMP V-219, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 18-May-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1433-01 1 Flakons, 10 deva -
V/NRP/02/1433-02 5 Flakons, 10 deva -
V/NRP/02/1433-03 1 Flakons, 20 deva -
V/NRP/02/1433-04 5 Flakons, 20 deva -
V/NRP/02/1433-05 1 Flakons, 40 deva -
V/NRP/02/1433-06 5 Flakons, 40 deva -
V/NRP/02/1433-07 1 Flakons, 50 deva -
V/NRP/02/1433-08 5 Flakons, 50 deva -
V/NRP/02/1433-09 1 Flakons, 80 deva -
V/NRP/02/1433-10 5 Flakons, 80 deva -
V/NRP/02/1433-11 1 Flakons, 100 deva -
V/NRP/02/1433-12 5 Flakons, 100 deva -
V/NRP/02/1433-13 1 Flakons, 50 deva -
V/NRP/02/1433-14 5 Flakons, 50 deva -
V/NRP/02/1433-15 1 Flakons, 100 deva -
V/NRP/02/1433-16 5 Flakons, 100 deva -
V/NRP/02/1433-17 1 Flakons, 1 deva -
V/NRP/02/1433-18 5 Flakons, 1 deva -
V/NRP/02/1433-19 10 Flakons, 1 deva -
Advantage 80 mg V/NRP/25/0030 Elanco Animal Health GmbH, Vācija QP53AX17 large cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bayer HealthCare AG, Vācija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/25/0030-01 80 mg 2 Polipropilēna pipete, 0,8 ml -
V/NRP/25/0030-02 80 mg 3 Polipropilēna pipete, 0,8 ml -
V/NRP/25/0030-03 80 mg 4 Polipropilēna pipete, 0,8 ml -
V/NRP/25/0030-04 80 mg 6 Polipropilēna pipete, 0,8 ml -
Suramox 500 mg/g V/NRP/08/1717 Virbac S.A., Francija QJ01CA04 chickens Vairāk

Medicinal product information

Pharmaceutical form: powder for oral solution
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release FC France SAS, Francija
Date of authorisation/renewal: 16-Oct-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1717-01 500 mg/g 1 Burciņa, 50 g -
V/NRP/08/1717-02 500 mg/g 1 Burciņa, 100 g -
V/NRP/08/1717-03 500 mg/g 1 Burciņa, 200 g -
V/NRP/08/1717-04 500 mg/g 1 Burciņa, 500 g -
V/NRP/08/1717-05 500 mg/g 1 Burciņa, 1000 g -
V/NRP/08/1717-06 500 mg/g 1 muciņa, 1500 g -
V/NRP/08/1717-07 500 mg/g 1 muciņa, 3000 g -
V/NRP/08/1717-08 500 mg/g 1 Maisiņš, 500 g -
V/NRP/08/1717-09 500 mg/g 1 Maisiņš, 1000 g -
V/NRP/08/1717-10 500 mg/g 1 Maisiņš, 2000 g -
V/NRP/08/1717-11 500 mg/g 1 Maisiņš, 3000 g -
Suramox 500 mg/g V/NRP/08/1716 Virbac S.A., Francija QJ01CA04 pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for oral solution
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release FC France SAS, Francija
Date of authorisation/renewal: 16-Oct-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1716-01 500 mg/g 1 Burciņa, 50 g -
V/NRP/08/1716-02 500 mg/g 1 Burciņa, 100 g -
V/NRP/08/1716-03 500 mg/g 1 Burciņa, 200 g -
V/NRP/08/1716-04 500 mg/g 1 Burciņa, 500 g -
V/NRP/08/1716-05 500 mg/g 1 Burciņa, 1000 g -
V/NRP/08/1716-06 500 mg/g 1 muciņa, 1500 g -
V/NRP/08/1716-07 500 mg/g 1 muciņa, 3000 g -
V/NRP/08/1716-08 500 mg/ml 1 Maisiņš, 500 g -
V/NRP/08/1716-09 500 mg/g 1 Maisiņš, 1000 g -
V/NRP/08/1716-10 500 mg/g 1 Maisiņš, 2000 g -
V/NRP/08/1716-11 500 mg/g 1 Maisiņš, 3000 g -

3081 record

© Food and veterinary service · 2026 Cookies policy